ADAPTIMMUNE THERAPEUTICS PLC Total Liabilities and Equity
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Total Liabilities and Equity of $130.63 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2025-08-13
- 2025-06-30: Liabilities and Equity $130.63M.
- 2025-03-31: Liabilities and Equity $158.07M.
- 2024-12-31: Liabilities and Equity $245.96M.
- 2024-09-30: Liabilities and Equity $317.44M.
| Period end | Liabilities and Equity |
|---|---|
| 2025-06-30 | $130.63M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $158.07M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $245.96M 10-Q · filed 2025-08-13 |
| 2024-09-30 | $317.44M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $321.70M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $258.01M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $282.62M 10-K · filed 2025-03-24 |
| 2023-09-30 | $296.64M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $342.98M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $288.08M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $328.92M 10-K · filed 2024-03-06 |
| 2022-09-30 | $332.20M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $388.27M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $419.80M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $469.55M 10-K · filed 2023-03-06 |
| 2021-09-30 | $353.53M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $389.79M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $411.58M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $451.14M 10-K · filed 2022-03-14 |
| 2020-09-30 | $479.02M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $512.20M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $285.24M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $181.54M 10-K · filed 2021-02-25 |
| 2019-09-30 | $208.25M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $239.52M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $270.44M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $276.74M 10-K · filed 2020-02-27 |
| 2018-09-30 | $309.63M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $211.30M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $247.07M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $281.15M 10-K · filed 2019-02-27 |
| 2017-09-30 | $301.38M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $284.28M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $265.98M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $234.51M 10-K · filed 2018-03-15 |
| 2016-09-30 | $222.64M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $239.56M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $261.56M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $285.82M 10-K · filed 2017-03-13 |
| 2015-06-30 | $300.65M 10-K · filed 2017-03-13 |
| 2014-06-30 | $55.73M 8-K · filed 2016-07-08 |